cannabinol has been researched along with hu 243 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Compton, DR; Khanolkar, AD; Makriyannis, A; Martin, BR; Yan, G; Yin, D | 1 |
| Barg, J; Bayewitch, M; Breuer, A; Hanus, L; Levy, R; Mechoulam, R; Rhee, MH; Vogel, Z | 1 |
2 other study(ies) available for cannabinol and hu 243
| Article | Year |
|---|---|
Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist.
Topics: Analgesia; Animals; Body Temperature; Cannabinoids; Cannabinol; Catalepsy; Chromatography, High Pressure Liquid; Dronabinol; Mice; Motor Activity; Stereoisomerism; Structure-Activity Relationship | 1994 |
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
Topics: Adenylyl Cyclase Inhibitors; Animals; Brain; Cannabinoids; Cannabinol; Catalepsy; CHO Cells; COS Cells; Cricetinae; Enzyme Inhibitors; Humans; Kinetics; Mice; Models, Chemical; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Synaptosomes; Transfection | 1997 |